G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1.

MLA

Exposito, Francisco, et al. “G9a/DNMT1 Co-Targeting Inhibits Non-Small Cell Lung Cancer Growth and Reprograms Tumor Cells to Respond to Cancer-Drugs through SCARA5 and AOX1.” Cell Death & Disease, vol. 15, no. 11, Nov. 2024, p. 787. EBSCOhost, https://doi.org/10.1038/s41419-024-07156-w.

APA

Exposito, F., Redrado, M., Serrano, D., Calabuig-Fariñas, S., Bao-Caamano, A., Gallach, S., Jantus-Lewintre, E., Diaz-Lagares, A., Rodriguez-Casanova, A., Sandoval, J., San Jose-Eneriz, E., Garcia, J., Redin, E., Senent, Y., Leon, S., Pio, R., Lopez, R., Oyarzabal, J., Pineda-Lucena, A., … Calvo, A. (2024). G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1. Cell Death & Disease, 15(11), 787. https://doi.org/10.1038/s41419-024-07156-w

Chicago

Exposito, Francisco, Miriam Redrado, Diego Serrano, Silvia Calabuig-Fariñas, Aida Bao-Caamano, Sandra Gallach, Eloisa Jantus-Lewintre, et al. 2024. “G9a/DNMT1 Co-Targeting Inhibits Non-Small Cell Lung Cancer Growth and Reprograms Tumor Cells to Respond to Cancer-Drugs through SCARA5 and AOX1.” Cell Death & Disease 15 (11): 787. doi:10.1038/s41419-024-07156-w.